Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer

The expression of IL-17A and programmed death ligand 1 (PDL1) is increased in estrogen receptor-negative breast cancer. IL-17A promotes tumor cell survival and invasiveness and inhibits the antitumor immune response. The PDL1–PD1 (programmed death protein 1) signaling pathway promotes escape from im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yun-Feng, Chen, Chen, Li, Dongqing, Liu, Min, Lv, Zhuang-Wei, Ji, Yanhong, Xu, Jiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352347/
https://www.ncbi.nlm.nih.gov/pubmed/27935862
http://dx.doi.org/10.18632/oncotarget.13819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352347/
https://www.ncbi.nlm.nih.gov/pubmed/27935862
http://dx.doi.org/10.18632/oncotarget.13819

Ejemplares similares